Literature DB >> 21946028

An update in endoscopic management of gastric cancer.

Alexandra Retana1, Taryn Silverstein, Wahid Wassef.   

Abstract

PURPOSE OF REVIEW: Gastric cancer remains a prevalent disease with a 5-year mortality rate of less than 25%. This review focuses on the endoscopic detection, staging, and management of gastric adenocarcinoma. RECENT
FINDINGS: Confocal laser endomicroscopy and narrow band imaging have a 77-99.4% sensitivity for early cancer detection, a significant improvement when compared with white light endoscopy. Proper staging can be accomplished through endoscopic ultrasound and multidetector row-computed tomography, with accuracy as high as 90.1%. Endoscopic management of early gastric cancer is minimally invasive and can be preferable to surgery. In properly selected patients, endoscopic submucosal dissection has been found to have 100% 5-year survival.
SUMMARY: The recent advances in gastric cancer have greatly improved the care we can offer our patients in gastric oncology. The emerging technologies will hopefully continue to promote this trend.

Entities:  

Mesh:

Year:  2011        PMID: 21946028     DOI: 10.1097/MOG.0b013e32834b9e5e

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  3 in total

1.  Can we resect EGC with Signet ring cells in Europe?

Authors:  Fabrice Caillol; Erwan Bories; Jerôme Guiramand; Christian Pesenti; Florat Poizat; Geneviève Monges; Marc Giovannini
Journal:  J Gastrointest Cancer       Date:  2013-12

2.  Gastric juice miR-129 as a potential biomarker for screening gastric cancer.

Authors:  Xing Yu; Lin Luo; Yibo Wu; Xiuchong Yu; Yang Liu; Xuelin Yu; Xiaoyan Zhao; Xinjun Zhang; Long Cui; Guoliang Ye; Yanping Le; Junming Guo
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

3.  Feasibility and safety of endoscopic submucosal dissection of esophageal or gastric carcinomas under general anesthesia.

Authors:  Qiu-Hua Rong; Guo-Li Zhao; Jia-Ping Xie; Le-Xin Wang
Journal:  Med Princ Pract       Date:  2012-11-16       Impact factor: 1.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.